<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2025.1634056</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Automatic measurement of mesenteric vascular and portal vein parameters via PE-NET in the diagnosis of Crohn&#x2019;s disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Weize</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3197922/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Liangfang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Kun</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1904493/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>He</surname>
<given-names>Bosheng</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2706570/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Radiology, Affiliated Hospital 2 of Nantong University</institution>, <addr-line>Nantong, Jiangsu</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Electrical Engineering and Automation, Nantong University</institution>, <addr-line>Nantong, Jiangsu</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Clinical and Translational Medicine Center, Affiliated Hospital 2 of Nantong University</institution>, <addr-line>Nantong, Jiangsu</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1500611/overview">Rafael S. Czepielewski</ext-link>, Augusta University, United States</p>
</fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2170004/overview">Pavlo Petakh</ext-link>, Uzhhorod National University, Ukraine</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3133020/overview">Daniel Lee</ext-link>, Washington University in St. Louis, United States</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Kun Zhang, <email>Zhangkun_nt@163.com</email></corresp>
<corresp id="c002">Bosheng He, <email>boshenghe@126.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1634056</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Xu, Zheng, Zhang and He.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Xu, Zheng, Zhang and He</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Objective</title>
<p>Vascular changes are concomitant of the course of Crohn&#x2019;s disease (CD). In this study, we evaluated the value of the parallel encoder network (PE-NET) method for the automated measurement of mesenteric vascular and portal vein parameters and explored the performance of PE-NET combined with support vector machine (SVM) classifier in CD diagnosis.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>The automatic vascular segmentation model was trained using computed tomography enterography (CTE) imaging data from our hospital based on PE-NET. The segmentation performance of the trained model was evaluated using the sensitivity (SEN), the Dice Similarity Coefficient (DSC), and the Average Hausdorff Distance (AHD). Then, the model was used for the automatic measurement of vascular parameters in the classification set, and machine learning classifier SVM was applied based on selected vessel features. The diagnosis performance of the PE-NET&#x202F;+&#x202F;SVM model was evaluated and compared with that of human radiologists and the clinical biomarkers [C-reactive protein (CRP) and fecal calprotectin (FCP)]. The impact of PE-NET&#x202F;+&#x202F;SVM on the reading time of radiologists was also evaluated.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>The segmentation dataset included the CTE data from 54 CD patients and 20 healthy controls. The classification dataset included the CTE data from 40 CD patients and 45 healthy controls. We found that PE-NET performed well in the vascular segmentation of the superior mesenteric artery (SMA), portal vein (PV), and abdominal aorta (AA) in both validation sets and the testing set. Vascular parameters were automatically extracted by PE-NET. We found that the mesenteric artery, portal vein, abdominal aorta, and the ratio of portal vein to superior mesenteric artery or abdominal aorta were increased in the testing set, with no statistical difference between the automatic measurement obtained using PE-NET and the manual evaluation of CTE. Moreover, an support vector machine (SVM) classifier was applied for CD diagnosis based on the vascular parameters. The F1 scores indicated the comparable diagnostic ability of PE-NET&#x202F;+&#x202F;SVM to senior radiologists with over 10&#x202F;years of experience, and the receiver operating curves (ROCs) revealed that the area under the curve (AUC) of PE-NET&#x202F;+&#x202F;SVM was 0.934, which was higher than those of clinical biomarkers such as FCP (AUC of 0.913) and CRP (AUC of 0.893), suggesting the great potential of PE-NET in aiding CD diagnosis. Additionally, the reading time of a junior radiologist on CTE images was significantly reduced and comparable to that of a senior radiologist with the help of PE-NET.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>The PE-NET enables the automated measurement of mesenteric vascular and portal vein parameters and potentially assists the efficient diagnosis of CD.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Crohn&#x2019;s disease</kwd>
<kwd>PE-NET</kwd>
<kwd>deep learning</kwd>
<kwd>computed tomography enterography</kwd>
<kwd>mesenteric vascular</kwd>
<kwd>portal vein</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="7"/>
<equation-count count="0"/>
<ref-count count="28"/>
<page-count count="9"/>
<word-count count="5992"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Translational Medicine</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<title>Introduction</title>
<p>Crohn&#x2019;s disease (CD) is a chronic inflammatory disease of the gastrointestinal tract, with increasing incidence globally (<xref ref-type="bibr" rid="ref1">1</xref>). It is more prevalent in patients younger than 30&#x202F;years, and the course of this disease is progressive with relapsing attacks, along with intestinal complications such as fibrosis and colorectal cancer (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref2">2</xref>). The early diagnosis is of vital significance for the effective treatment and outcomes of CD patients. Currently, although less invasive biomarkers such as C-reactive protein and Erythrocyte sedimentation rate (ESR) correlate with disease activity, the specificity remains a challenge. Consequently, the diagnosis of CD still relies on endoscopy and histological examinations, and the inherent limitations such as the invasiveness, the tolerance of patients, and the inability to examine segments proximal to the terminal ileum affect the accurate diagnosis of CD (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>). The delayed diagnosis often occurs due to the time lag between the onset of inflammation and the appearance of signs and symptoms, leading to an increased risk of adverse complications (<xref ref-type="bibr" rid="ref5">5</xref>). Therefore, it is essential to develop novel methods for the early and effective diagnosis of CD.</p>
<p>Imaging examination is also an important part of CD diagnosis. Increasing evidence has shown that cross-sectional imaging techniques such as CT, MRI, and ultrasound serve as useful approaches for CD diagnosis. Although both endoscopic and imaging examinations can monitor the disease activity, the imaging techniques are also valuable in monitoring CD progression (<xref ref-type="bibr" rid="ref6">6</xref>, <xref ref-type="bibr" rid="ref7">7</xref>). CT and MRI manifestations, such as mucosal hyperenhancement, wall thickening, and comb sign, have been revealed to be associated with active inflammation in CD (<xref ref-type="bibr" rid="ref8">8</xref>). Moreover, the abnormalities in vascular alteration are associated with the inflammation and progression of CD (<xref ref-type="bibr" rid="ref9">9</xref>). However, the evaluation of imaging features such as mesenteric and portal vascularity remains subjective, which makes it difficult to quantitatively compare these features with the severity of underlying inflammation and bowel injury.</p>
<p>In recent years, deep learning techniques have attracted increasing attention in the field of medical image analysis. Among the deep learning algorithms, the convolutional neural networks (CNNs) have performed well with excellent feature extraction and expression capabilities in computer vision and are widely used in classification, segmentation, object detection, and registration (<xref ref-type="bibr" rid="ref10">10</xref>). The establishment of 2D and 3D U-Net has been widely used for the processing of medical images, and automatic segmentation algorithms based on these models have been used for organs, tissues, and vessels; however, the accuracy for small vessel segmentation remains unsatisfactory (<xref ref-type="bibr" rid="ref11">11</xref>). PE-NET is a parallel encoder network suitable for the analysis of multimodal data in medical imaging, such as CT and MRI (<xref ref-type="bibr" rid="ref12">12</xref>). Compared with the previous U-Net, which struggles in processing the large-scale change of vessels, the PE-NET algorithm with a self-adaptive feature shows great potential in the visualization of the whole vessel. Currently, the PE-NET has been applied for the segmentation of the inferior mesenteric artery in the abdomen (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref13">13</xref>). However, the value of PE-NET in CD diagnosis remains largely unknown.</p>
<p>In this study, we aimed to investigate the performance of PE-NET in abdominal vascular segmentation and evaluate the value of PE-NET for the automated measurement of mesenteric vascular and portal vein parameters in the diagnosis of CD. The findings of this study might provide novel insights into the detection and management of CD.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<title>Materials and methods</title>
<sec id="sec7">
<title>Study design</title>
<p>This retrospective study was conducted at our hospital. The PE-NET model, established as previously described, was applied in this study (<xref ref-type="bibr" rid="ref12">12</xref>).</p>
</sec>
<sec id="sec8">
<title>Study subjects</title>
<p>To train the model, this study collected the imaging data and other relevant clinical data of 54 CD patients admitted to our hospital from January 2014 to December 2024 and 20 healthy control individuals without intestinal inflammation (validated by endoscopic examination). The training/validation set included 63 cases, and the testing set included 11 patients. The external validation dataset included 20 abdominal images of CD patients and 20 abdominal images of healthy controls obtained from the open public database.<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> For the datasets used for the classification model, a total of 85 cases were included, with 30 cases in the training/validation set and 55 cases in the testing set. The study was approved by the Ethics Committee of our hospital and conforms to the principles of the Declaration of Helsinki. The inclusion criteria were as follows: (1) CD patients confirmed by histological examination, (2) those with CTE imaging data, (3) those who underwent endoscopic examination before or after imaging examination; and (4) those with comprehensive clinical data. The exclusion criteria were as follows: (1) patients who received abdominal surgery before the examination; (2) patients with scanning images of poor quality; and (3) patients with comorbidities such as cancer, coronary heart disease, and other gastrointestinal diseases.</p>
</sec>
<sec id="sec9">
<title>CT imaging</title>
<p>The CT scanning was conducted using a FORCE CT scanner (Siemens, Berlin, Germany). Patients were instructed to undergo standard bowel preparation before the CT examination, including a low-slag diet 2&#x202F;days before the examination, a liquid diet 1&#x202F;day before the examination, and fasting for 4&#x2013;8&#x202F;h before the examination. The scan area was from the top of the diaphragm to the lower margin of the pubis, and patients were in the supine position. The scan parameters were set as follows: tube voltage at A: 90&#x202F;kV, B: Sn150 kV, tube current at A: 144 mass, B: 90 mAs, pitch of 1.0, speed of 0.5&#x202F;s, collimation of 2&#x202F;&#x00D7;&#x202F;192&#x202F;&#x00D7;&#x202F;0.6&#x202F;mm, slice thickness of 1&#x202F;mm, and slice gap of 1&#x202F;mm. Patients were first injected with 75&#x202F;mL of iopromide (370&#x202F;mgI/ml) at 3.5&#x202F;mL/s in the antecubital vein and then with 20&#x2013;30&#x202F;mL of normal saline. The monitoring methods were applied based on a three-stage enhanced scanning automatic tracking technique. When the aortic monitoring threshold reached 100 HU, the arterial phase scan was triggered. The venous phase scan was performed 40&#x202F;s later, followed by a delayed phase scan conducted 80&#x202F;s after completion of the venous phase scan. The images were sent to a post-processing workstation (syngo via, VB20, Siemens Medical Solutions, Forchheim, Germany) for further processing.</p>
</sec>
<sec id="sec10">
<title>Processing and analysis of CT images</title>
<p>The 120 kVP images with a slice thickness of 1&#x202F;mm were obtained after inputting the raw data into the post-processing workstation. The virtual monoenergetic images with computational fusion were also obtained under the dual energy Mono+ mode (40&#x2013;90 KeV) with the slice thickness of 1&#x202F;mm. The cross-sectional images with a slice thickness of 3&#x202F;mm and a slice gap of 3&#x202F;mm were reconstructed for the above images. Two radiologists, each with over 10&#x202F;years of experience and blinded to patient information, delineated the vessels. This was reviewed by a specialist with over 20&#x202F;years of experience in abdominal imaging diagnosis. The robustness assessment was conducted in cases with anatomical variability or disease-induced deformation by evaluating the ability of the model in visualizing major vascular variants compared to the expected anatomical course based on CT images. The vessels delineated in consensus by radiologists were referred to as the ground truth. <xref ref-type="fig" rid="fig1">Figure 1</xref> shows the example of CT images from a CD patient and a healthy control individual.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Computed tomography enterography (CTE) images from <bold>(A)</bold> a CD patient and <bold>(B)</bold> a healthy control individual.</p>
</caption>
<graphic xlink:href="fmed-12-1634056-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Two sets of computed tomography scans labeled A and B are shown. Each set comprises two images presenting axial cross-sections of the abdomen with varying contrast levels. Details of internal organs and anatomical structures are visible, indicating potential analysis of abdominal conditions or pathologies.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec11">
<title>PE-NET model</title>
<p>PE-NET was established as previously described (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref13">13</xref>). It is a novel parallel network combining a transformer with CNN and is composed of a contracting path (encoder), an expanding path (decoder), and skip connections.</p>
</sec>
<sec id="sec12">
<title>Feature fusion and classification</title>
<p>The features of vessel parameters were fused and input into a support vector machine (SVM) for diagnosis, with the parameters of C&#x202F;=&#x202F;1, gamma&#x202F;=&#x202F;&#x2018;scale&#x2019;, kernel&#x202F;=&#x202F;&#x2018;rbf&#x2019;, and degree&#x202F;=&#x202F;3.</p>
</sec>
<sec id="sec13">
<title>Observational indicators</title>
<p>(1) To validate the performance of the model, voxel-based metrics including the sensitivity (SEN), Dice Similarity Coefficient (DSC), and Average Hausdorff Distance (AHD) were evaluated. Considering vascular connectivity, the evaluation of AHD is of top priority, followed by the DSC and SEN values.</p>
<p>(2) The vascular morphological characteristics, such as the diameter of superior and inferior mesenteric artery, the portal vein, and the abdominal aorta, were measured. The ratio of the portal vein/aorta or the portal vein/superior mesenteric artery diameter was evaluated to minimize the effect of patient size.</p>
<p>(3) Observer studies: Four radiologists of varying experience were included in the observation studies. The diagnostic performance of PE-NET&#x202F;+&#x202F;SVM was compared with that of human radiologists using F1 scores. The inter-rater consistency among human radiologists was evaluated using Cohen&#x2019;s kappa scores.</p>
<p>(4) Traditional imaging indicators obtained from CT imaging were evaluated, including multisegmental bowel involvement, bowel wall thickening, mural stratification, mesenteric vessel engorgement, lymph node enlargement, and increased mesenteric fat density.</p>
</sec>
<sec id="sec14">
<title>Statistical analysis</title>
<p>SPSS 23.0 software and GraphPad Prism 8.0 software were used for data analysis. The Shapiro&#x2013;Wilk test was used to evaluate the normal distribution of the data. For data that conformed to normal distribution, the measurement data were shown as the mean&#x202F;&#x00B1;&#x202F;SD and evaluated using Student&#x2019;s <italic>t</italic>-test. Categorical data were shown as the frequency and percentage (%), and comparisons between groups were conducted using the chi-square test. For measurement data that did not conform to normal distribution, data were shown as the median (Q25 and Q75) and compared with the Mann&#x2013;Whitney <italic>U</italic> test. A <italic>p</italic>-value of &#x003C;0.05 was regarded as a statistically significant difference.</p>
</sec>
</sec>
<sec sec-type="results" id="sec15">
<title>Results</title>
<sec id="sec16">
<title>Clinicopathological features of CD patients in the segmentation set</title>
<p>This study included 54 CD patients and healthy control individuals. The mean age was 25.32&#x202F;&#x00B1;&#x202F;4.36 for CD patients and 26.24&#x202F;&#x00B1;&#x202F;3.96 for healthy controls. Among the CD patients, 17 were women and 37 were men. There were 8 women and 12 men in the healthy control group. There was no statistical significance between the baseline characteristics, including age and sex of CD patients and healthy controls (<italic>p</italic>&#x202F;&#x003E;&#x202F;0.05), while the CRP and ESR levels of CD patients were significantly higher than those of the healthy controls, and the BMI of CD patients was significantly lower relative to healthy controls (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). Moreover, the CTE showed that, among CD patients, 26 had multisegmental bowel involvement, 31 had mural stratification, 40 showed comb signs, 12 had lymph node enlargement, 54 showed bowel wall thickening and mesenteric fat thickness of 0.85&#x202F;&#x00B1;&#x202F;0.42, which were all significantly higher compared with the healthy controls (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="table" rid="tab1">Table 1</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Baseline clinical characteristics of CD patients and control individuals in the segmentation cohort.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Variables</th>
<th align="center" valign="top">CD patients (<italic>n</italic> =&#x202F;54)</th>
<th align="center" valign="top">Healthy controls (<italic>n</italic> =&#x202F;20)</th>
<th align="center" valign="top"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Age (years)</td>
<td align="center" valign="top">25.31&#x202F;&#x00B1;&#x202F;4.35</td>
<td align="center" valign="top">26.20&#x202F;&#x00B1;&#x202F;3.93</td>
<td align="center" valign="top">0.428</td>
</tr>
<tr>
<td align="left" valign="top">Sex</td>
<td/>
<td/>
<td align="center" valign="top">0.491</td>
</tr>
<tr>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">17 (31.48)</td>
<td align="center" valign="top">8</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Male</td>
<td align="center" valign="top">37 (68.52)</td>
<td align="center" valign="top">12</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">BMI (kg/m<sup>2</sup>)</td>
<td align="center" valign="top">20.85&#x202F;&#x00B1;&#x202F;1.27</td>
<td align="center" valign="top">22.20&#x202F;&#x00B1;&#x202F;3.27</td>
<td align="center" valign="top">0.013</td>
</tr>
<tr>
<td align="left" valign="top" colspan="4">Location</td>
</tr>
<tr>
<td align="left" valign="top">L1 (ileum)</td>
<td align="center" valign="top">12 (22.22)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">L2 (colon)</td>
<td align="center" valign="top">0 (0)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">L3 (ileocolon)</td>
<td align="center" valign="top">42 (77.78)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top" colspan="4">Disease activity</td>
</tr>
<tr>
<td align="left" valign="top">Mild</td>
<td align="center" valign="top">18 (33.33)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Moderate&#x2013;severe</td>
<td align="center" valign="top">36 (66.67)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abdominal pain</td>
<td align="center" valign="top">31 (57.41)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Diarrhea</td>
<td align="center" valign="top">29 (53.70)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Fever</td>
<td align="center" valign="top">6 (11.11)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Weight loss</td>
<td align="center" valign="top">16 (29.63)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Bloody stools</td>
<td align="center" valign="top">8 (14.81)</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">FCP (&#x03BC;g/g)</td>
<td align="center" valign="top">789 (383.7,1,052)</td>
<td align="center" valign="top">24.76 (21.3,33.05)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">CRP (mg/L)</td>
<td align="center" valign="top">13.86 (11.36,18.33)</td>
<td align="center" valign="top">2.75 (1.86, 4.50)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">ESR (mm/h)</td>
<td align="center" valign="top">48 (27,59)</td>
<td align="center" valign="top">6.5 (4, 14.5)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top" colspan="4">CT features</td>
</tr>
<tr>
<td align="left" valign="top">Multisegmental bowel involvement</td>
<td align="center" valign="top">26</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Mural stratification</td>
<td align="center" valign="top">31</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Comb sign</td>
<td align="center" valign="top">40</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Lymph node enlargement (&#x003E;1&#x202F;cm in short diameter)</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.021</td>
</tr>
<tr>
<td align="left" valign="top">Bowel wall thickening (&#x003E;3&#x202F;mm)</td>
<td align="center" valign="top">54</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Mesenteric Fat Thickness (cm)</td>
<td align="center" valign="top">0.85&#x202F;&#x00B1;&#x202F;0.42</td>
<td align="center" valign="top">0.61&#x202F;&#x00B1;&#x202F;0.23</td>
<td align="center" valign="top">0.018</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>CD, Crohn&#x2019;s disease; FCP, fecal calprotectin; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec17">
<title>Assessment of the segmentation performance of PE-NET</title>
<p>Data from 74 participants (54 CD patients and 20 healthy controls) were used for modeling, of which data from 63 cases were used for the training and validation sets and those from 11 cases were used for the testing set. The automated segmentation performance of the model was evaluated with the five-fold cross-validation and compared against the ground truth expert-labeled segmentations. The data of 20 CD cases and 20 healthy controls from a public dataset were used for external validation. The segmentation performance of PE-NET of each type of vessel (SMA, PV, and AA) was tested and evaluated as shown in <xref ref-type="table" rid="tab2">Table 2</xref>. The model showed comparable SEN, DSC, and AHD across the three cohorts, although the SEN and DSC values in the external validation group were slightly slower, and the AHD were slightly higher for PV segmentation compared with the internal validation group.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>The segmentation performance in SMA, PV, and AA across cohorts.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="2">Vessels</th>
<th align="center" valign="top" colspan="3">SEN (%)</th>
<th align="center" valign="top" colspan="3">Dice (%)</th>
<th align="center" valign="top" colspan="3">AHD</th>
</tr>
<tr>
<th align="center" valign="top">Internal validation set<break/>(<italic>n</italic> =&#x202F;10)</th>
<th align="center" valign="top">Testing set<break/>(<italic>n</italic> =&#x202F;11)</th>
<th align="center" valign="top">External validation set (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top">Internal validation set<break/>(<italic>n</italic> =&#x202F;10)</th>
<th align="center" valign="top">Testing set<break/>(<italic>n</italic> =&#x202F;11)</th>
<th align="center" valign="top">External validation set (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top">Internal validation set<break/>(<italic>n</italic> =&#x202F;10)</th>
<th align="center" valign="top">Testing set<break/>(<italic>n</italic> =&#x202F;11)</th>
<th align="center" valign="top">External validation set (<italic>n</italic> =&#x202F;40)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">SMA</td>
<td align="center" valign="top">93.23&#x202F;&#x00B1;&#x202F;6.41</td>
<td align="center" valign="top">91.88&#x202F;&#x00B1;&#x202F;5.49</td>
<td align="center" valign="top">92.72&#x202F;&#x00B1;&#x202F;6.43</td>
<td align="center" valign="top">92.88&#x202F;&#x00B1;&#x202F;5.32</td>
<td align="center" valign="top">92.24&#x202F;&#x00B1;&#x202F;5.61</td>
<td align="center" valign="top">90.39&#x202F;&#x00B1;&#x202F;5.74</td>
<td align="center" valign="top">5.33&#x202F;&#x00B1;&#x202F;4.45</td>
<td align="center" valign="top">5.58&#x202F;&#x00B1;&#x202F;4.52</td>
<td align="center" valign="top">5.22&#x202F;&#x00B1;&#x202F;4.59</td>
</tr>
<tr>
<td align="left" valign="top">PV</td>
<td align="center" valign="top">91.83&#x202F;&#x00B1;&#x202F;4.58</td>
<td align="center" valign="top">89.68&#x202F;&#x00B1;&#x202F;5.63</td>
<td align="center" valign="top">89.21&#x202F;&#x00B1;&#x202F;4.97</td>
<td align="center" valign="top">89.29&#x202F;&#x00B1;&#x202F;4.70</td>
<td align="center" valign="top">87.48&#x202F;&#x00B1;&#x202F;4.59</td>
<td align="center" valign="top">85.29&#x202F;&#x00B1;&#x202F;6.18</td>
<td align="center" valign="top">6.19&#x202F;&#x00B1;&#x202F;4.56</td>
<td align="center" valign="top">6.67&#x202F;&#x00B1;&#x202F;4.55</td>
<td align="center" valign="top">7.21&#x202F;&#x00B1;&#x202F;5.60</td>
</tr>
<tr>
<td align="left" valign="top">AA</td>
<td align="center" valign="top">90.04&#x202F;&#x00B1;&#x202F;5.25</td>
<td align="center" valign="top">88.62&#x202F;&#x00B1;&#x202F;6.94</td>
<td align="center" valign="top">88.75&#x202F;&#x00B1;&#x202F;5.77</td>
<td align="center" valign="top">87.60&#x202F;&#x00B1;&#x202F;4.81</td>
<td align="center" valign="top">85.91&#x202F;&#x00B1;&#x202F;5.07</td>
<td align="center" valign="top">85.14&#x202F;&#x00B1;&#x202F;5.16</td>
<td align="center" valign="top">7.36&#x202F;&#x00B1;&#x202F;4.82</td>
<td align="center" valign="top">7.74&#x202F;&#x00B1;&#x202F;5.27</td>
<td align="center" valign="top">7.33&#x202F;&#x00B1;&#x202F;5.41</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>SMA, superior mesenteric artery; PV, portal vein; AA, abdominal aorta; AHD, Average Hausdorff Distance.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec18">
<title>Measurement of mesenteric vascular and portal vein parameters</title>
<p>The accuracy of the automatic segmentation by PE-NET was evaluated in the testing set. As measured by PE-NET or CTE evaluation, the diameter of the superior mesenteric artery, the inferior mesenteric artery (IMA), the portal vein, and the abdominal aorta (AA), as well as the ratio of portal vein (PV)/superior mesenteric artery (SMA) and PV/AA diameter was significantly increased in CD patients compared with the control group (<xref ref-type="fig" rid="fig2">Figures 2A</xref>&#x2013;<xref ref-type="fig" rid="fig2">F</xref>). Moreover, we found that the bias of mesenteric vascular, portal vein, and abdominal aorta parameters between PE-NET and CTE evaluation showed no significant difference, which indicated minimal systemic error. Overall, these data revealed that PE-NET performed well in the automated measurement of mesenteric vascular and portal vein parameters as well as in the calculation of PV/SMA and PV/AA diameter.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>The measurement accuracy of mesenteric vascular and portal vein parameters by PE-NET. The diameter of <bold>(A)</bold> superior mesenteric artery (SMA), <bold>(B)</bold> inferior mesenteric artery (IMA), <bold>(C)</bold> portal vein (PV), and <bold>(D)</bold> abdominal aorta (AA), as well as <bold>(E)</bold> the ratio of PV/SMA and <bold>(F)</bold> PV/AA in control and CD patients in the testing set were assessed via PE-NET automatic measurement or CTE evaluation. Ns, non-significant; &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, &#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001.</p>
</caption>
<graphic xlink:href="fmed-12-1634056-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar graphs showing vessel diameters in centimeters for various arteries and veins, comparing control and CD groups for PE-NET and CTE. Panels A to F display superior and inferior mesenteric arteries, portal vein, abdominal aorta, and PV diameter ratios. Significant differences are marked with asterisks; ns indicates no significant difference.</alt-text>
</graphic>
</fig>
<p>For the evaluation of vascular variants (<xref ref-type="table" rid="tab3">Table 3</xref>), the successful visualization rate of the model was 50% (1 of 2) and 66.67% (2 of 3) in the internal validation and testing groups, respectively.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Detection of vascular variations based on PE-NET.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Dataset</th>
<th align="center" valign="top">Variations</th>
<th align="center" valign="top">Detection rate (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Internal validation set</td>
<td align="center" valign="top">SMA&#x202F;&#x2192;&#x202F;RHA (N&#x202F;=&#x202F;2)</td>
<td align="center" valign="top">1 (50%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Testing set</td>
<td align="center" valign="top">SMA&#x202F;&#x2192;&#x202F;RHA (N&#x202F;=&#x202F;1)</td>
<td align="center" valign="top">2 (66.67%)</td>
</tr>
<tr>
<td align="center" valign="top">SMA&#x202F;&#x2192;&#x202F;CHA (N&#x202F;=&#x202F;2)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>SMA, superior mesenteric artery; CHA, common hepatic artery; RHA, right hepatic artery.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec19">
<title>Assessment of classification results based on SVM machine learning method</title>
<p>The SVM classifier was applied based on the vessel parameters automatically measured by PE-NET in the classification set. The classifying accuracy reached 81.82% (Sensitivity: 75.86%; Specificity: 88.46%), and the AUC value of the SVM model was 0.934 in the testing set (<xref ref-type="table" rid="tab4">Table 4</xref>). <xref ref-type="fig" rid="fig3">Figure 3</xref> shows the importance of the permutation feature for the SVM model and highlights the contribution of the selected features to the diagnostic efficiency. The results indicated the top importance of the PV diameter to the SVM model.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Classification performance of the SVM machine learning model.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Dataset</th>
<th align="center" valign="top">AUC</th>
<th align="center" valign="top">Accuracy (%)</th>
<th align="center" valign="top">SEN (%)</th>
<th align="center" valign="top">SPE (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Training set</td>
<td align="center" valign="top">0.955</td>
<td align="center" valign="top">85.45</td>
<td align="center" valign="top">86.96</td>
<td align="center" valign="top">84.38</td>
</tr>
<tr>
<td align="left" valign="top">Validation set</td>
<td align="center" valign="top">0.881</td>
<td align="center" valign="top">80</td>
<td align="center" valign="top">71.43</td>
<td align="center" valign="top">81.48</td>
</tr>
<tr>
<td align="left" valign="top">Testing set</td>
<td align="center" valign="top">0.934</td>
<td align="center" valign="top">81.82</td>
<td align="center" valign="top">75.86</td>
<td align="center" valign="top">88.46</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>The permutation feature importance in the SVM classifier.</p>
</caption>
<graphic xlink:href="fmed-12-1634056-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar chart showing SVM permutation feature importance. Features are PV, AA, IMA, SMA, PV.SMA, and PV.AA. The x-axis indicates the decrease in accuracy, ranging from 0.00 to 0.15. PV has the highest importance, followed by AA, IMA, SMA, PV.SMA, and PV.AA.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec20">
<title>Comparison between PE-NET&#x202F;+&#x202F;SVM and human radiologists or clinical biomarkers in diagnosis performance</title>
<p>The diagnosis performance of the PE-NET&#x202F;+&#x202F;SVM model alone was compared with that of human radiologists with varying expertise using F1 scores. The results showed that the model exhibited better performance compared with junior human radiologists with over 5&#x202F;years of experience and nearly comparable performance to the senior human radiologists with over 10&#x202F;years of experience (<xref ref-type="table" rid="tab5">Table 5</xref>). When combined with the PE-NET&#x202F;+&#x202F;SVM model, the junior human radiologists showed improved F1 scores that were comparable to the senior human radiologists without PE-NET&#x202F;+&#x202F;SVM model assistance. We also found that the F1 scores of senior human radiologists were increased with the aid of the PE-NET&#x202F;+&#x202F;SVM model, suggesting the model as a promising tool in aiding the clinical diagnosis of radiologists. Additionally, the human expert variability was evaluated by Cohen&#x2019;s kappa scores, and inconsistencies were observed between the junior and senior radiologists. The results suggested that applying the PE-NET&#x202F;+&#x202F;SVM model might exert improved stability in clinical diagnosis (<xref ref-type="table" rid="tab6">Table 6</xref>).</p>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>F1 scores of the PE-NET&#x202F;+&#x202F;SVM model and human radiologists in CD diagnosis.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>Participant</th>
<th align="center" valign="top">Years of experience</th>
<th align="center" valign="top">F1 score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Radiologist 1</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.735</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 1&#x202F;+&#x202F;model</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">0.863</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 2</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.724</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 2&#x202F;+&#x202F;model</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">0.846</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 3</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">0.844</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 3&#x202F;+&#x202F;model</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">0.923</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 4</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">0.84</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 4&#x202F;+&#x202F;model</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">0.941</td>
</tr>
<tr>
<td align="left" valign="top">Model</td>
<td align="center" valign="top">NA</td>
<td align="center" valign="top">0.815</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap position="float" id="tab6">
<label>Table 6</label>
<caption>
<p>Inter-rater consistency of four human radiologists.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>Rater (row)</th>
<th align="center" valign="top">Radiologist 1</th>
<th align="center" valign="top">Radiologist 2</th>
<th align="center" valign="top">Radiologist 3</th>
<th align="center" valign="top">Radiologist 4</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Radiologist 1</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">0.420</td>
<td align="center" valign="top">0.235</td>
<td align="center" valign="top">0.227</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 2</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">0.237</td>
<td align="center" valign="top">0.238</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 3</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">0.854</td>
</tr>
<tr>
<td align="left" valign="top">Radiologist 4</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">&#x2013;</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Moreover, we also compared the diagnostic ability of the PE-NET&#x202F;+&#x202F;SVM model with two clinical biomarkers (FCP and CRP) of CD. The results of the ROC analysis showed that the AUC value was 0.934 for the model, 0.913 for FCP, and 0.893 for CRP in the testing set, which indicated the good performance of the PE-NET&#x202F;+&#x202F;SVM model in CD diagnosis (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>The diagnostic ability of PE-NET compared with blood and fecal biomarkers on CD.</p>
</caption>
<graphic xlink:href="fmed-12-1634056-g004.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">ROC curve comparing three models with axes labeled in percentages. The black line represents the model with the highest AUC of 0.934, followed by a blue line for FCP with an AUC of 0.913, and a green line for CRP with an AUC of 0.893. The red dotted line indicates the diagonal baseline.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec21">
<title>The effects of PE-NET&#x202F;+&#x202F;SVM model on the diagnostic efficiency of CD patients</title>
<p>Moreover, we evaluated the potential of PE-NET in improving the diagnostic efficiency of CD. The results showed that the average reading time and total reading time for a junior radiologist (radiologist 1) were significantly reduced with the aid of PE-NET&#x202F;+&#x202F;SVM model and comparable to that of a senior radiologist (radiologist 3), while the average reading time for a senior radiologist (radiologist 3) was not evidently decreased by the application of PE-NET&#x202F;+&#x202F;SVM. The results suggested that the diagnostic efficiency of junior radiologists was improved with the help of the PE-NET&#x202F;+&#x202F;SVM model. Though the reading time was not significantly decreased for a senior radiologist, the application of the model might potentially reduce their burden in correcting the mistakes of junior radiologists and decrease the misdiagnosis or missed diagnosis in the clinic (<xref ref-type="table" rid="tab7">Table 7</xref>).</p>
<table-wrap position="float" id="tab7">
<label>Table 7</label>
<caption>
<p>Effects of PE-NET&#x202F;+&#x202F;SVM model on the diagnostic efficiency of radiologists.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>Measurement</th>
<th align="center" valign="top">Radiologist 1</th>
<th align="center" valign="top">Radiologist 1&#x202F;+&#x202F;model</th>
<th align="center" valign="top">Radiologist 3</th>
<th align="center" valign="top">Radiologist 3&#x202F;+&#x202F;model</th>
<th align="center" valign="top"><italic>P<sup>1</sup></italic></th>
<th align="center" valign="top"><italic>P<sup>2</sup></italic></th>
<th align="center" valign="top"><italic>P<sup>3</sup></italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Time (min)</td>
<td align="center" valign="top">5.9&#x202F;&#x00B1;&#x202F;1.1</td>
<td align="center" valign="top">4.4&#x202F;&#x00B1;&#x202F;0.8</td>
<td align="center" valign="top">4.2&#x202F;&#x00B1;&#x202F;1.2</td>
<td align="center" valign="top">4.1&#x202F;&#x00B1;&#x202F;1.1</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.981</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Total time</td>
<td align="center" valign="top">321.8</td>
<td align="center" valign="top">239.3</td>
<td align="center" valign="top">230.8</td>
<td align="center" valign="top">226.6</td>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>P1 indicates the statistical difference between the Radiologist 1 and Radiologist 1&#x202F;+&#x202F;model. P2 indicates the statistical difference between Radiologist 3 and Radiologist 3&#x202F;+&#x202F;model. P3 indicates the statistical difference between Radiologist 1&#x202F;+&#x202F;model and Radiologist 3.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="sec22">
<title>Discussion</title>
<p>Crohn&#x2019;s disease (CD) is a lifelong chronic intestinal inflammatory disease, with an incidence peak between the second and fourth decades of life, significantly affecting the quality of life of patients (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref15">15</xref>). Early diagnosis is essential for the determination of long-term therapeutic plans. Endoscopic and histological evaluation is essential for the confirmation of CD, while the application is limited by the inability to observe the bowel wall architecture, the subjective interpretation, and the low tolerance of patients (<xref ref-type="bibr" rid="ref16">16</xref>). The non-invasive diagnostic methods such as cross-sectional imaging show higher tolerance and are valuable not only for the early examination but also for monitoring of the disease progression (<xref ref-type="bibr" rid="ref6">6</xref>, <xref ref-type="bibr" rid="ref17">17</xref>). In this study, we developed a PE-NET model for automated measurement of mesenteric vascular and portal vein parameters, and the combination with SVM classifier enables the discrimination of CD disease activity. The segmentation and classification performance of the PE-NET&#x202F;+&#x202F;SVM was validated, and the diagnostic efficiency of CD was improved with the help of PE-NET&#x202F;+&#x202F;SVM.</p>
<p>Accumulating evidence has shown that vascular changes, including angiogenesis and lymphangiogenesis are crucially involved in CD progression (<xref ref-type="bibr" rid="ref18 ref19 ref20 ref21">18&#x2013;21</xref>). Notably, the enlarged artery or portal vein vessels, which have been observed in CD patients, are likely related to the increasing requirement of oxygen and nutrients of the affected segment in the course of CD (<xref ref-type="bibr" rid="ref22">22</xref>). For example, the mesenteric components, such as the vascular system, are involved in the gut dysbiosis-adaptive immunity-mesentery-body axis and are critically associated with the CD progression (<xref ref-type="bibr" rid="ref9">9</xref>). The mesenteric blood flow based on MRI has been linked with intestinal inflammation in CD patients, with a positive correlation between the blood flow and C-reactive protein and fecal calprotectin (<xref ref-type="bibr" rid="ref23">23</xref>). A study by Yekeler et al. (<xref ref-type="bibr" rid="ref24">24</xref>) has also revealed that the mean diameter and flow volume of the superior mesenteric artery (SMA) are increased in active CD patients than in inactive CD patients. A study has evaluated the difference in splanchnic vascular flow by measuring the transverse diameters of the main portal vein and abdominal aorta and found elevated diameters in the portal vein and portal vein/aorta ratio in CD patients (<xref ref-type="bibr" rid="ref22">22</xref>). Therefore, exploring the alteration of abdominal vessels such as the SMA and portal vein can potentially contribute to the diagnosis of CD.</p>
<p>In recent years, deep learning techniques-based segmentation methods have boasted the automatic processing of CT images for detection and classification tasks (<xref ref-type="bibr" rid="ref25 ref26 ref27 ref28">25&#x2013;28</xref>). However, it remains a challenging task to automatically segment abdominal vessels because of the multi-scale nature of vessels, blurred boundaries, low contrast, and vascular cracks in Maximum Intensity Projection (MIP) images. In this study, the PE-NET method is used for the automatic segmentation of abdominal vessels, including the SMA, the portal vein, and the abdominal aorta. This network applied a new network architecture CGS that integrates redundant features in space into the target vessel to obtain the maximum coronal vessel (<xref ref-type="bibr" rid="ref13">13</xref>). Compared with other deep learning models, such as 3D U-net, AU, and CAS models in vessel segmentation, PE-NET shows higher sensitivity and lower AHD (<xref ref-type="bibr" rid="ref12">12</xref>). Our model performs well in capturing the overall vascular structure, especially in learning vascular edge features, while the 3D U-net, AU, and CAS models showed under-segmentation in tiny vessels, and extensive vascular disconnections at varying degrees (<xref ref-type="bibr" rid="ref12">12</xref>). Compared with the segmentation by junior radiologists, the PE-NET showed improved performance with relatively higher F1 scores, suggesting the usability of this method in abdominal vessel segmentation. Moreover, the automatic measurement of mesenteric vascular and portal vein parameters showed no significant difference with the ground-truth measurement results, and the results indicated the increase in diameter of SMA, IMA, PV, and AA, as well as the ratio of PV/SMA and PV/AA, which are consistent with the previous findings (<xref ref-type="bibr" rid="ref22">22</xref>).</p>
<p>Accurate and efficient assessment of disease is of vital importance for the monitoring and treatment of CD. In our study, we revealed the ability of PE-NET with an SVM classifier in the diagnosis of CD patients. Compared with blood and fecal biomarkers, the PE-NET with SVM classifier showed a relatively higher AUC and increased specificity, suggesting great potential in clinical CD diagnosis. Additionally, the reading time of CT images for a junior radiologist was significantly decreased with the help of PE-NET&#x202F;+&#x202F;SVM and was comparable to that of a senior radiologist. Although the reading time of a senior radiologist was not significantly improved by PE-NET&#x202F;+&#x202F;SVM, their burden of correcting the junior radiologists can possibly be eased.</p>
<p>Despite the advantage of the PE-NET model, this study also possesses some limitations. First, the sample size of the dataset used in this study was relatively small, which potentially caused model overfitting and influenced the generalizability of the model. Second, the CT images used for generating the training and internal validation set were obtained from a single institution using a Siemens FORCE CT scanner. While the five-fold cross-validation was used to improve the model robustness and external validation was conducted using imaging data from an open-source database, future research is warranted to include more imaging modalities and data from multiple centers to enhance the generalizability and validate the performance as well as clinical applicability of the model across different scanners, acquisition parameters, or institutions.</p>
<p>In conclusion, this study applied the PE-NET method for the automatic evaluation of mesenteric vascular and portal vein parameters, with good performance in vascular segmentation, demonstrated great performance in CD diagnosis compared with blood and fecal biomarkers, with high sensitivity and specificity, and improved the diagnostic efficiency of radiologists. Given the potential of PE-NET in CD diagnosis, the findings of this study might provide novel insight into the CD detection and management in the future.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec23">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/supplementary material.</p>
</sec>
<sec sec-type="ethics-statement" id="sec24">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Ethics committee of Nantong City No. 1 People&#x2019;s Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec sec-type="author-contributions" id="sec25">
<title>Author contributions</title>
<p>WX: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. LZ: Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft. KZ: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. BH: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec26">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="sec27">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec28">
<title>Generative AI statement</title>
<p>The authors declare that no Gen AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec29">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<fn id="fn0001"><p><sup>1</sup><ext-link xlink:href="https://crohnipi.ls2n.fr/en/crohn-ipi-project/" ext-link-type="uri">https://crohnipi.ls2n.fr/en/crohn-ipi-project/</ext-link></p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roda</surname><given-names>G</given-names></name> <name><surname>Chien Ng</surname><given-names>S</given-names></name> <name><surname>Kotze</surname><given-names>PG</given-names></name> <name><surname>Argollo</surname><given-names>M</given-names></name> <name><surname>Panaccione</surname><given-names>R</given-names></name> <name><surname>Spinelli</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Crohn's disease</article-title>. <source>Nat Rev Dis Primers</source>. (<year>2020</year>) <volume>6</volume>:<fpage>22</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41572-020-0156-2</pub-id>, PMID: <pub-id pub-id-type="pmid">32242028</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saevik</surname><given-names>F</given-names></name></person-group>. <article-title>Prediction of postoperative recurrence in Crohn's disease: where do we go from Here?</article-title> <source>Clin Gastroenterol Hepatol</source>. (<year>2023</year>) <volume>21</volume>:<fpage>3017</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cgh.2023.02.027</pub-id>, PMID: <pub-id pub-id-type="pmid">36871773</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>CA</given-names></name> <name><surname>Berinstein</surname><given-names>JA</given-names></name> <name><surname>Louissaint</surname><given-names>J</given-names></name> <name><surname>Higgins</surname><given-names>PDR</given-names></name> <name><surname>Spence</surname><given-names>JR</given-names></name> <name><surname>Shannon</surname><given-names>C</given-names></name> <etal/></person-group>. <article-title>Biomarkers for the prediction and diagnosis of Fibrostenosing Crohn's disease: a systematic review</article-title>. <source>Clin Gastroenterol Hepatol</source>. (<year>2022</year>) <volume>20</volume>:<fpage>817</fpage>&#x2013;<lpage>46.e10</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cgh.2021.05.054</pub-id>, PMID: <pub-id pub-id-type="pmid">34089850</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>N&#x00FA;&#x00F1;ez</surname><given-names>FP</given-names></name> <name><surname>Krugliak Cleveland</surname><given-names>N</given-names></name> <name><surname>Quera</surname><given-names>R</given-names></name> <name><surname>Rubin</surname><given-names>DT</given-names></name></person-group>. <article-title>Evolving role of endoscopy in inflammatory bowel disease: going beyond diagnosis</article-title>. <source>World J Gastroenterol</source>. (<year>2021</year>) <volume>27</volume>:<fpage>2521</fpage>&#x2013;<lpage>30</lpage>.</citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>H</given-names></name> <name><surname>Li</surname><given-names>HY</given-names></name> <name><surname>Zhang</surname><given-names>HN</given-names></name> <name><surname>Liu</surname><given-names>Y</given-names></name></person-group>. <article-title>Delayed diagnosis in inflammatory bowel disease: time to consider solutions</article-title>. <source>World J Gastroenterol</source>. (<year>2024</year>) <volume>30</volume>:<fpage>3954</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v30.i35.3954</pub-id>, PMID: <pub-id pub-id-type="pmid">39351057</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rimola</surname><given-names>J</given-names></name> <name><surname>Torres</surname><given-names>J</given-names></name> <name><surname>Kumar</surname><given-names>S</given-names></name> <name><surname>Taylor</surname><given-names>SA</given-names></name> <name><surname>Kucharzik</surname><given-names>T</given-names></name></person-group>. <article-title>Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease</article-title>. <source>Gut</source>. (<year>2022</year>) <volume>71</volume>:<fpage>2587</fpage>&#x2013;<lpage>97</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2021-326562</pub-id>, PMID: <pub-id pub-id-type="pmid">35927032</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiorino</surname><given-names>G</given-names></name> <name><surname>Morin</surname><given-names>M</given-names></name> <name><surname>Bonovas</surname><given-names>S</given-names></name> <name><surname>Bonifacio</surname><given-names>C</given-names></name> <name><surname>Spinelli</surname><given-names>A</given-names></name> <name><surname>Germain</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Prevalence of bowel damage assessed by cross-sectional imaging in early Crohn's disease and its impact on disease outcome</article-title>. <source>J Crohns Colitis</source>. (<year>2017</year>) <volume>11</volume>:<fpage>274</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjw185</pub-id>, PMID: <pub-id pub-id-type="pmid">27799269</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiorean</surname><given-names>MV</given-names></name> <name><surname>Sandrasegaran</surname><given-names>K</given-names></name> <name><surname>Saxena</surname><given-names>R</given-names></name> <name><surname>Maglinte</surname><given-names>DD</given-names></name> <name><surname>Nakeeb</surname><given-names>A</given-names></name> <name><surname>Johnson</surname><given-names>CS</given-names></name></person-group>. <article-title>Correlation of CT enteroclysis with surgical pathology in Crohn's disease</article-title>. <source>Am J Gastroenterol</source>. (<year>2007</year>) <volume>102</volume>:<fpage>2541</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1572-0241.2007.01537.x</pub-id>, PMID: <pub-id pub-id-type="pmid">17900329</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Y</given-names></name> <name><surname>Zhu</surname><given-names>ZX</given-names></name> <name><surname>Li</surname><given-names>Z</given-names></name> <name><surname>Chen</surname><given-names>YS</given-names></name> <name><surname>Zhu</surname><given-names>WM</given-names></name></person-group>. <article-title>Role of mesenteric component in Crohn's disease: a friend or foe?</article-title> <source>World J Gastroint Surg</source>. (<year>2021</year>) <volume>13</volume>:<fpage>1536</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.4240/wjgs.v13.i12.1536</pub-id>, PMID: <pub-id pub-id-type="pmid">35070062</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dayarathna</surname><given-names>S</given-names></name> <name><surname>Islam</surname><given-names>KT</given-names></name> <name><surname>Uribe</surname><given-names>S</given-names></name> <name><surname>Yang</surname><given-names>G</given-names></name> <name><surname>Hayat</surname><given-names>M</given-names></name> <name><surname>Chen</surname><given-names>Z</given-names></name></person-group>. <article-title>Deep learning based synthesis of MRI, CT and PET: review and analysis</article-title>. <source>Med Image Anal</source>. (<year>2024</year>) <volume>92</volume>:<fpage>103046</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.media.2023.103046</pub-id>, PMID: <pub-id pub-id-type="pmid">38052145</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mileto</surname><given-names>A</given-names></name> <name><surname>Yu</surname><given-names>L</given-names></name> <name><surname>Revels</surname><given-names>JW</given-names></name> <name><surname>Kamel</surname><given-names>S</given-names></name> <name><surname>Shehata</surname><given-names>MA</given-names></name> <name><surname>Ibarra-Rovira</surname><given-names>JJ</given-names></name> <etal/></person-group>. <article-title>State-of-the-art deep learning CT reconstruction algorithms in abdominal imaging</article-title>. <source>Radiographics</source>. (<year>2024</year>) <volume>44</volume>:<fpage>e240095</fpage>. doi: <pub-id pub-id-type="doi">10.1148/rg.240095</pub-id>, PMID: <pub-id pub-id-type="pmid">39612283</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K</given-names></name> <name><surname>Xu</surname><given-names>P</given-names></name> <name><surname>Wang</surname><given-names>M</given-names></name> <name><surname>Lin</surname><given-names>P</given-names></name> <name><surname>Crookes</surname><given-names>D</given-names></name> <name><surname>He</surname><given-names>B</given-names></name> <etal/></person-group>. <article-title>PE-net: a parallel framework for 3D inferior mesenteric artery segmentation</article-title>. <source>Front Physiol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1308987</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2023.1308987</pub-id>, PMID: <pub-id pub-id-type="pmid">38169744</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>KZYHPXMWJYP</given-names></name></person-group>. <article-title>Multi-scale deep information and adaptive attention mechanism based coronary reconstruction of superior mesenteric artery</article-title>. <source>IEEE Access</source>. (<year>2023</year>) <volume>11</volume>:<fpage>4042</fpage>&#x2013;<lpage>56</lpage>.</citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cockburn</surname><given-names>E</given-names></name> <name><surname>Kamal</surname><given-names>S</given-names></name> <name><surname>Chan</surname><given-names>A</given-names></name> <name><surname>Rao</surname><given-names>V</given-names></name> <name><surname>Liu</surname><given-names>T</given-names></name> <name><surname>Huang</surname><given-names>JY</given-names></name> <etal/></person-group>. <article-title>Crohn's disease: an update</article-title>. <source>Clin Med (Lond)</source>. (<year>2023</year>) <volume>23</volume>:<fpage>549</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.7861/clinmed.2023-0493</pub-id>, PMID: <pub-id pub-id-type="pmid">38065612</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Berre</surname><given-names>C</given-names></name> <name><surname>Ananthakrishnan</surname><given-names>AN</given-names></name> <name><surname>Danese</surname><given-names>S</given-names></name> <name><surname>Singh</surname><given-names>S</given-names></name> <name><surname>Peyrin-Biroulet</surname><given-names>L</given-names></name></person-group>. <article-title>Ulcerative colitis and Crohn's disease have similar burden and goals for treatment</article-title>. <source>Clin Gastroenterol Hepatol</source>. (<year>2020</year>) <volume>18</volume>:<fpage>14</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cgh.2019.07.005</pub-id>, PMID: <pub-id pub-id-type="pmid">31301452</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daperno</surname><given-names>M</given-names></name></person-group>. <article-title>Endoscopy in IBD: when and how?</article-title> <source>Diagnostics</source>. (<year>2023</year>) <volume>13</volume>:<fpage>3423</fpage>. doi: <pub-id pub-id-type="doi">10.3390/diagnostics13223423</pub-id>, PMID: <pub-id pub-id-type="pmid">37998559</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YD</given-names></name> <name><surname>Zhang</surname><given-names>RN</given-names></name> <name><surname>Mao</surname><given-names>R</given-names></name> <name><surname>Li</surname><given-names>XH</given-names></name></person-group>. <article-title>Inflammatory bowel disease cross-sectional imaging: what's new?</article-title> <source>United European Gastroenterol J</source>. (<year>2022</year>) <volume>10</volume>:<fpage>1179</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ueg2.12343</pub-id>, PMID: <pub-id pub-id-type="pmid">36461914</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zanoli</surname><given-names>L</given-names></name> <name><surname>Rastelli</surname><given-names>S</given-names></name> <name><surname>Inserra</surname><given-names>G</given-names></name> <name><surname>Castellino</surname><given-names>P</given-names></name></person-group>. <article-title>Arterial structure and function in inflammatory bowel disease</article-title>. <source>World J Gastroenterol</source>. (<year>2015</year>) <volume>21</volume>:<fpage>11304</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v21.i40.11304</pub-id>, PMID: <pub-id pub-id-type="pmid">26523102</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spalinger</surname><given-names>J</given-names></name> <name><surname>Patriquin</surname><given-names>H</given-names></name> <name><surname>Miron</surname><given-names>MC</given-names></name> <name><surname>Marx</surname><given-names>G</given-names></name> <name><surname>Herzog</surname><given-names>D</given-names></name> <name><surname>Dubois</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity</article-title>. <source>Radiology</source>. (<year>2000</year>) <volume>217</volume>:<fpage>787</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiology.217.3.r00dc19787</pub-id>, PMID: <pub-id pub-id-type="pmid">11110944</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name> <name><surname>Zhu</surname><given-names>W</given-names></name> <name><surname>Zuo</surname><given-names>L</given-names></name> <name><surname>Shen</surname><given-names>B</given-names></name></person-group>. <article-title>The role of the mesentery in Crohn's disease: the contributions of nerves, vessels, lymphatics, and fat to the pathogenesis and disease course</article-title>. <source>Inflamm Bowel Dis</source>. (<year>2016</year>) <volume>22</volume>:<fpage>1483</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MIB.0000000000000791</pub-id>, PMID: <pub-id pub-id-type="pmid">27167572</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name> <name><surname>Ge</surname><given-names>Y</given-names></name> <name><surname>Gong</surname><given-names>J</given-names></name> <name><surname>Zhu</surname><given-names>W</given-names></name> <name><surname>Cao</surname><given-names>L</given-names></name> <name><surname>Guo</surname><given-names>Z</given-names></name> <etal/></person-group>. <article-title>Mesenteric lymphatic vessel density is associated with disease behavior and postoperative recurrence in Crohn's disease</article-title>. <source>J Gastrointest Surg</source>. (<year>2018</year>) <volume>22</volume>:<fpage>2125</fpage>&#x2013;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11605-018-3884-9</pub-id>, PMID: <pub-id pub-id-type="pmid">30043133</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>C</given-names></name> <name><surname>Yoon</surname><given-names>H</given-names></name> <name><surname>Park</surname><given-names>S</given-names></name> <name><surname>Kim</surname><given-names>J</given-names></name> <name><surname>Han</surname><given-names>K</given-names></name> <name><surname>Kim</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Initial abdominal CT and laboratory findings prior to diagnosis of Crohn's disease in children</article-title>. <source>Yonsei Med J</source>. (<year>2022</year>) <volume>63</volume>:<fpage>675</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.3349/ymj.2022.63.7.675</pub-id>, PMID: <pub-id pub-id-type="pmid">35748079</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ata</surname><given-names>NA</given-names></name> <name><surname>Dillman</surname><given-names>JR</given-names></name> <name><surname>Gandhi</surname><given-names>D</given-names></name> <name><surname>Dudley</surname><given-names>JA</given-names></name> <name><surname>Trout</surname><given-names>AT</given-names></name> <name><surname>Imbus</surname><given-names>R</given-names></name> <etal/></person-group>. <article-title>Velocity-encoded phase-contrast MRI for measuring mesenteric blood flow in patients with newly diagnosed small-bowel Crohn disease</article-title>. <source>AJR Am J Roentgenol</source>. (<year>2022</year>) <volume>219</volume>:<fpage>132</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.2214/AJR.22.27437</pub-id>, PMID: <pub-id pub-id-type="pmid">35195433</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yekeler</surname><given-names>E</given-names></name> <name><surname>Danalioglu</surname><given-names>A</given-names></name> <name><surname>Movasseghi</surname><given-names>B</given-names></name> <name><surname>Yilmaz</surname><given-names>S</given-names></name> <name><surname>Karaca</surname><given-names>C</given-names></name> <name><surname>Kaymakoglu</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Crohn disease activity evaluated by Doppler ultrasonography of the superior mesenteric artery and the affected small-bowel segments</article-title>. <source>J Ultrasound Med</source>. (<year>2005</year>) <volume>24</volume>:<fpage>59</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.7863/jum.2005.24.1.59</pub-id>, PMID: <pub-id pub-id-type="pmid">15615929</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minaee</surname><given-names>S</given-names></name> <name><surname>Boykov</surname><given-names>Y</given-names></name> <name><surname>Porikli</surname><given-names>F</given-names></name> <name><surname>Plaza</surname><given-names>A</given-names></name> <name><surname>Kehtarnavaz</surname><given-names>N</given-names></name> <name><surname>Terzopoulos</surname><given-names>D</given-names></name></person-group>. <article-title>Image segmentation using deep learning: a survey</article-title>. <source>IEEE Trans Pattern Anal Mach Intell</source>. (<year>2022</year>) <volume>44</volume>:<fpage>3523</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1109/TPAMI.2021.3059968</pub-id>, PMID: <pub-id pub-id-type="pmid">33596172</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name> <name><surname>Wang</surname><given-names>X</given-names></name> <name><surname>Zhang</surname><given-names>K</given-names></name> <name><surname>Fung</surname><given-names>KM</given-names></name> <name><surname>Thai</surname><given-names>TC</given-names></name> <name><surname>Moore</surname><given-names>K</given-names></name> <etal/></person-group>. <article-title>Recent advances and clinical applications of deep learning in medical image analysis</article-title>. <source>Med Image Anal</source>. (<year>2022</year>) <volume>79</volume>:<fpage>102444</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.media.2022.102444</pub-id>, PMID: <pub-id pub-id-type="pmid">35472844</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name> <name><surname>Diao</surname><given-names>Z</given-names></name> <name><surname>Shi</surname><given-names>T</given-names></name> <name><surname>Zhou</surname><given-names>Y</given-names></name> <name><surname>Wang</surname><given-names>F</given-names></name> <name><surname>Hu</surname><given-names>W</given-names></name> <etal/></person-group>. <article-title>A review of deep learning-based multiple-lesion recognition from medical images: classification, detection and segmentation</article-title>. <source>Comput Biol Med</source>. (<year>2023</year>) <volume>157</volume>:<fpage>106726</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.compbiomed.2023.106726</pub-id>, PMID: <pub-id pub-id-type="pmid">36924732</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Best</surname><given-names>WR</given-names></name> <name><surname>Becktel</surname><given-names>JM</given-names></name> <name><surname>Singleton</surname><given-names>JW</given-names></name> <name><surname>Kern</surname><given-names>F</given-names></name></person-group>. <article-title>Development of a Crohn's disease activity index. National Cooperative Crohn's disease study</article-title>. <source>Gastroenterology</source>. (<year>1976</year>) <volume>70</volume>:<fpage>439</fpage>&#x2013;<lpage>44</lpage>.</citation></ref>
</ref-list>
</back>
</article>